The top psychedelic drug developers leading the market
Nova Mentis to Present at the H.C. Wainwright Mental Health Conference
NMLSF) to Present at the H.C. Wainwright Mental Health Conference
New DMT Study Shows Positive Results for Depression
Women With MS Utilize Social Media to Discuss, Share Safety Concerns on DMT Use During Pregnancy
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy
Long-term Use by MS Patients in US of Initial DMT 'Low,' Study Finds – Multiple Sclerosis News Today
At RRMS Diagnosis, 'Hidden' Disabilities Fairly Common, Study Finds – Multiple Sclerosis News Today
Multiple Sclerosis and COVID-19: Illness Severity and Mortality
New Data at AAN 2022 Highlight Real-World Evidence from
New Data at AAN 2022 Highlight Real-World Evidence from Biogen's MS Portfolio and Emerging Research on Disease Progression – Financial Post
Electronic Health Records as a Prognostic Indicator of Outcome and a Clinical Discovery Platform
Single Psilocybin Dose Improves Treatment-Resistant Depression
